RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg

The national marketing approval in Luxembourg completes the current approval process of RIZAPORT® under the European Decentralized Procedure (DCP); RIZAPORT® is also approved for marketing in Germany and a national Marketing Authorization Applicati... Biopharmaceuticals, Drug Delivery, Regulatory RedHill Biopharma, IntelGenx, RIZAPORT, rizatriptan, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news